Pegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma)

聚乙二醇化重组人粒细胞刺激因子(石药集团)

Report date: 2026/05/13 20:02:10

Base Information

Drug NamePegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma)
Drug Alias Name聚乙二醇化重组人粒细胞刺激因子生物lieJinyouli聚乙二醇化重组人粒细胞刺激因子生物fangPEG-rhG-CSF (CSPC Pharma)津优力 +[6
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2011/10/21
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA13
Related LinksN/A